NCT05868928View on ClinicalTrials.gov

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

RecruitingOBSERVATIONAL
Enrollment

132

Participants

Timeline

Start Date

December 7, 2023

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
Brain MetastasesRadiosurgery
Interventions
DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

Pre-and post-contrast enhanced T1-weighted image, T2-weighted image, fluid-attenuated inversion recovery image

DIAGNOSTIC_TEST

Diffusion-weighted MRI

Diffusion-weighted MRI

DIAGNOSTIC_TEST

Arterial spin labeling (ASL)

Cerebral blood flow imaging parameter

DIAGNOSTIC_TEST

Dynamic susceptibility contrast-MRI (DSC-MRI)

Cerebral blood volume and vessel architectural imaging parameters

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT05868928 - Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis | Biotech Hunter | Biotech Hunter